On August 24, 2016, CTTI hosted a webinar on innovative approaches to transforming antibacterial drug development as recently featured in a Clinical Infectious Diseases (CID) supplement. The presentation highlighted the important role public-private partnerships play in advancing the field of antibacterial drug development and included an inside look at CTTI’s two new sets of recommendations for streamlining HABP/VABP trials. Thought leaders from CTTI, FDA, industry, and academia spoke, reflecting on the significance of this new body of work.
We are now pleased to share the webinar recording, in which you can hear more about:
Use of an evidence-based approach to characterize the challenges of studying new antibacterial drugs
Actionable solutions to these challenges developed from collaborations between multiple stakeholders
Ongoing work to determine the promise and potential implications of an early enrollment strategy for HABP/VABP trials